Goldman Sachs
VIVS

Goldman Sachs’s VivoSim Labs VIVS Stock Holding History

Goldman Sachs’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8
Closed -$7K – 7051
2016
Q4 		$7K Hold
8
– – ﹤0.01% 6795
2016
Q3 		$8K Buy
+8
New +$7.83K ﹤0.01% 6894
2015
Q4 		– Sell
-1,000
Closed -$643K – 7372
2015
Q3 		$643K Sell
1,000
-1,058
-51% -$804K ﹤0.01% 4898
2015
Q2 		$1.86M Buy
2,058
+205
+11% +$229K ﹤0.01% 3895
2015
Q1 		$1.57M Buy
1,853
+603
+48% +$833K ﹤0.01% 4017
2014
Q4 		$2.17M Hold
1,250
– – ﹤0.01% 3757
2014
Q3 		$1.91M Sell
1,250
-1,604
-56% -$2.91M ﹤0.01% 3976
2014
Q2 		$5.72M Buy
2,854
+1,375
+93% +$2.3M ﹤0.01% 2893
2014
Q1 		$2.71M Buy
+1,479
New +$3.43M ﹤0.01% 3673

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

Goldman Sachs's VIVS Position: Q2 2026 in Review

Goldman Sachs sold out of VivoSim Labs (VIVS) in Q2 2026, closing a stake of 16,072 shares — an estimated $23K sold.

Goldman Sachs first reported a position in VIVS in Q3 2013 and held it in 26 quarters. The position peaked at $6.36M in Q2 2014. 26 funds tracked by Wall St. Rank hold VIVS as of Q2 2026.

  • Goldman Sachs reported no remaining VivoSim Labs position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 16,072 VivoSim Labs shares in Q2 2026, an estimated $23K.
  • Goldman Sachs first reported a position in VivoSim Labs in Q3 2013 and held it in 26 quarters.
  • Goldman Sachs's VivoSim Labs position peaked at $6.36M in Q2 2014.
  • 26 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.